{
  "abstract": "First of all, we would like to thank Mukhdomi and colleagues for their letter1 regarding our article entitled ‘Low-dose ketamine infusion to facilitate opioid tapering in chronic non-cancer pain with opioid use disorder: a historical cohort study’.2",
  "authors": [
    {
      "affiliations": [
        "University Hospital Centre Toulouse, Toulouse, France",
        "General and Family Medicine University Department, Universite Toulouse III-Paul Sabatier, Toulouse, France"
      ],
      "name": "Antoine Elyn"
    },
    {
      "affiliations": [
        "University Hospital Centre Toulouse, Toulouse, France",
        "Université Toulouse III-Paul Sabatier, Toulouse, France"
      ],
      "name": "Anne Roussin"
    },
    {
      "affiliations": [
        "University Hospital Centre Toulouse, Toulouse, France"
      ],
      "name": "Cécile Lestrade"
    },
    {
      "affiliations": [
        "University Hospital Centre Toulouse, Toulouse, France",
        "Université Toulouse III-Paul Sabatier, Toulouse, France"
      ],
      "name": "Nicolas Franchitto"
    },
    {
      "affiliations": [
        "University Hospital Centre Toulouse, Toulouse, France"
      ],
      "name": "Bénédicte Jullian"
    },
    {
      "affiliations": [
        "University Hospital Centre Toulouse, Toulouse, France"
      ],
      "name": "Nathalie Cantagrel"
    }
  ],
  "title": "Response to ‘Growing evidence supports low-dose ketamine infusions to facilitate opioid tapering’",
  "uid": "218819b5-b520-525a-b16b-aefb7471849d"
}